Evidence map›Paper›PMID 31347507›Full record

ArticleThe journal of international advanced otology2020

The Effectiveness of Medical Prophylactic Treatment on Vestibular Migraine and Its Effect on the Quality Of Life.

Onur Çelik, Gökçe Tanyeri Toker, Görkem Eskiizmir, Armağan İncesulu, Nevin Şahin Süyür

Open access · diamondAbstract read
In one paragraph

Article in The journal of international advanced otology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Prophylactic Management of Vestibular Migraine: A Systematic Review.Annals of clinical and translational neurology · 2025
    Pooled it
  2. Pooled it
  3. Review
  4. Long-Term Effects of Intervention on Vestibular Migraine: A Preliminary Study.The Annals of otology, rhinology, and laryngology · 2024
    Article
  5. Review
  6. Update on diagnosis and differential diagnosis of vestibular migraine.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Onur ÇelikManisa Celal Bayar University, Department of Otorhinolaryngology, Manisa Turkey.
Gökçe Tanyeri TokerDepartment of Otorhinolaryngology, İzmir Katip Çelebi University, Ataturk Training and Research Hospital, İzmir, Turkey.
Görkem EskiizmirManisa Celal Bayar University, Department of Otorhinolaryngology, Manisa Turkey.
Armağan İncesuluDepartment of Otolaryngology, Eskişehir Osmangazi University School of Medicine, Eskişehir, Turkey.
Nevin Şahin SüyürClinic of Otorhinolaryngology, Ağrı Diyadin State Hospital, Ağrı, Turkey.
Manisa Celal Bayar University · TREskişehir Osmangazi University · TRIzmir Kâtip Çelebi University · TRState Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of the present study was to determine the efficacy of propranolol treatment in patients with vestibular migraine by the Visual Analog Scale, Dizziness Handicap Inventory (DHI), Vertigo Symptom Scale, and Vestibular Disorders Activities of Daily Living Scale (VADL) and its effect on the quality of life. MATERIALS AND

methodsThe study population consisted of 38 patients with vertigo/dizziness who underwent routine evaluation and vestibular examinations, were diagnosed with definitive vestibular migraine, and received the same medical treatment protocol (propranolol). The questionnaires and scales that were applied to the patients before and after treatment were evaluated. The results were evaluated with 95% confidence interval, and p<0.05 was accepted as statistically significant.

resultsThe mean age of the patients was 47.55 (18-75) years, and 27 (71%) patients were female, and 11 (29%) were male. The mean total scores of the DHI before and after treatment were 50.21±22.39 (range: 8-92) and 9.31±9.86 (range: 0-58), respectively (p<0.001). The degree of disability after treatment was low in all patients (p<0.001). The total scores of the VADL before and after treatment were 186.63±79.65 (range: 32-280) and 55.52±51.89 (range: 28-273), respectively (p<0.001). There was no correlation between these two scales (p=0.235).

conclusionTo our knowledge, this is the first study to evaluate both the efficacy of propranolol treatment and its effects on the quality of life in vestibular migraine. The severity, frequency, and number of attacks and disability scores were reduced, and the quality of life was improved in patients with vestibular migraine with propranolol treatment.

Indexed as

Activities of Daily LivingAdrenergic beta-AntagonistsAdultAgedCase-Control StudiesDizzinessFemaleHumansMaleMiddle AgedMigraine DisordersPropranololQuality of LifeSeverity of Illness IndexSurveys and QuestionnairesTreatment OutcomeAdrenergic beta-AntagonistsPropranolol

Identifiers

PMID31347507
PMCPMC7224423
OpenAlexW2964241743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.